Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High-Risk Prescribing and Incidence of Frailty Among Older Community-Dwelling Men
Danijela Gnjidic, Sarah N. Hilmer, Fiona Blyth, et al.
Clinical Pharmacology & Therapeutics (2012) Vol. 91, Iss. 3, pp. 521-528
Open Access | Times Cited: 283

Showing 1-25 of 283 citing articles:

What is polypharmacy? A systematic review of definitions
Nashwa Masnoon, Sepehr Shakib, Lisa M. Kalisch Ellett, et al.
BMC Geriatrics (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 2462
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
Danijela Gnjidic, Sarah N. Hilmer, Fiona Blyth, et al.
Journal of Clinical Epidemiology (2012) Vol. 65, Iss. 9, pp. 989-995
Closed Access | Times Cited: 1028
Health Outcomes Associated with Polypharmacy in Community‐Dwelling Older Adults: A Systematic Review
Terri R. Fried, John R. O’Leary, Virginia Towle, et al.
Journal of the American Geriatrics Society (2014) Vol. 62, Iss. 12, pp. 2261-2272
Open Access | Times Cited: 601
Global Incidence of Frailty and Prefrailty Among Community-Dwelling Older Adults
Richard Ofori‐Asenso, Ken Lee Chin, Mohsen Mazidi, et al.
JAMA Network Open (2019) Vol. 2, Iss. 8, pp. e198398-e198398
Open Access | Times Cited: 421
The relationship between frailty and polypharmacy in older people: A systematic review
Marta Gutiérrez‐Valencia, Míkel Izquierdo, Matteo Cesari, et al.
British Journal of Clinical Pharmacology (2018) Vol. 84, Iss. 7, pp. 1432-1444
Open Access | Times Cited: 359
Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project
Vasant Hirani, Vasi Naganathan, Fiona Blyth, et al.
Age and Ageing (2016) Vol. 46, Iss. 3, pp. 413-420
Open Access | Times Cited: 202
Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people
Marie Herr, Jean‐Marie Robine, Juliette Pinot, et al.
Pharmacoepidemiology and Drug Safety (2015) Vol. 24, Iss. 6, pp. 637-646
Closed Access | Times Cited: 198
Polypharmacy and Medication Management in Older Adults
Jennifer Kim, Abby Luck Parish
Nursing Clinics of North America (2017) Vol. 52, Iss. 3, pp. 457-468
Closed Access | Times Cited: 198
Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study
Kai‐Uwe Saum, Ben Schöttker, Andreas D. Meid, et al.
Journal of the American Geriatrics Society (2016) Vol. 65, Iss. 2
Open Access | Times Cited: 179
Treatment of chronic kidney disease in older populations
Seiji Kishi, Hiroyuki Kadoya, Naoki Kashihara
Nature Reviews Nephrology (2024) Vol. 20, Iss. 9, pp. 586-602
Closed Access | Times Cited: 18
Association between Frailty and Dementia: A Population-Based Study
Jenni Kulmala, Irma Nykänen, Minna Mänty, et al.
Gerontology (2013) Vol. 60, Iss. 1, pp. 16-21
Closed Access | Times Cited: 178
Sarcopenia Is Associated With Incident Disability, Institutionalization, and Mortality in Community-Dwelling Older Men: The Concord Health and Ageing in Men Project
Vasant Hirani, Fiona Blyth, Vasi Naganathan, et al.
Journal of the American Medical Directors Association (2015) Vol. 16, Iss. 7, pp. 607-613
Closed Access | Times Cited: 173
Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study
Nicola Veronese, Brendon Stubbs, Marianna Noale, et al.
Journal of the American Medical Directors Association (2017) Vol. 18, Iss. 7, pp. 624-628
Open Access | Times Cited: 165
Prevalence and Impact of Fall-Risk-Increasing Drugs, Polypharmacy, and Drug–Drug Interactions in Robust Versus Frail Hospitalised Falls Patients: A Prospective Cohort Study
Alexander Bennett, Danijela Gnjidic, Mark Gillett, et al.
Drugs & Aging (2014) Vol. 31, Iss. 3, pp. 225-232
Closed Access | Times Cited: 139
Prevalence and factors associated with polypharmacy in older people with cancer
Justin P. Turner, Sepehr Shakib, Nimit Singhal, et al.
Supportive Care in Cancer (2014) Vol. 22, Iss. 7, pp. 1727-1734
Closed Access | Times Cited: 133
Drug Burden Index in older adults: theoretical and practical issues
Lisa Kouladjian O’Donnell, Danijela Gnjidic, Timothy F. Chen, et al.
Clinical Interventions in Aging (2014), pp. 1503-1503
Open Access | Times Cited: 129
Polypharmacy cut-points in older people with cancer: how many medications are too many?
Justin P. Turner, Kris M. Jamsen, Sepehr Shakib, et al.
Supportive Care in Cancer (2015) Vol. 24, Iss. 4, pp. 1831-1840
Closed Access | Times Cited: 127
Frailty, Mycophenolate Reduction, and Graft Loss in Kidney Transplant Recipients
Mara McAdams‐DeMarco, Andrew Law, Jingwen Tan, et al.
Transplantation (2014) Vol. 99, Iss. 4, pp. 805-810
Open Access | Times Cited: 124
Associations Between Polypharmacy and Cognitive and Physical Capability: A British Birth Cohort Study
Mark James Rawle, Rachel Cooper, Diana Kuh, et al.
Journal of the American Geriatrics Society (2018) Vol. 66, Iss. 5, pp. 916-923
Open Access | Times Cited: 124
Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis
Katie Palmer, Emanuele Rocco Villani, Davide Liborio Vetrano, et al.
European Geriatric Medicine (2018) Vol. 10, Iss. 1, pp. 9-36
Closed Access | Times Cited: 122
Patient frailty: the elephant in the operating room
Ruth E. Hubbard, David Story
Anaesthesia (2013) Vol. 69, Iss. s1, pp. 26-34
Open Access | Times Cited: 119
Factors associated with the frailty syndrome in elderly individuals living in the urban area
Maycon Sousa Pegorari, Darlene Mara dos Santos Tavares
Revista Latino-Americana de Enfermagem (2014) Vol. 22, Iss. 5, pp. 874-882
Open Access | Times Cited: 117
A Scoping Review of Frailty and Acute Care in Middle-Aged and Older Individuals with Recommendations for Future Research
David B. Hogan, Colleen J. Maxwell, Jonathan Afilalo, et al.
Canadian Geriatrics Journal (2017) Vol. 20, Iss. 1
Open Access | Times Cited: 114
Polypharmacy as a Risk Factor for Clinically Relevant Sarcopenia: Results From the Berlin Aging Study II
Maximilian König, Dominik Spira, Ilja Demuth, et al.
The Journals of Gerontology Series A (2017) Vol. 73, Iss. 1, pp. 117-122
Open Access | Times Cited: 114
Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study
Shoshana H. Ballew, Yan Chen, Natalie Daya, et al.
American Journal of Kidney Diseases (2016) Vol. 69, Iss. 2, pp. 228-236
Open Access | Times Cited: 112
Page 1 - Next Page

Scroll to top